Kestra Medical Technologies Ltd.
Kestra Medical Technologies Ltd. (KMTS): 2 pipeline candidates · ~19 mo cash runway · 1 clinical trial. Updated within the last hour.
BioSniper Score
5-factor signal · derived from public data
18.8 months
0% dilution
Lead: Approved
2 candidates
N/A
1 buy · 10 sells (180d)
A transparent, data-derived signal for Kestra Medical Technologies Ltd.across cash runway, pipeline maturity & breadth, catalyst momentum and clinical/regulatory footprint. Each factor traces to tracked public filings — not an investment recommendation.
Key Financials
Market Cap
$1.1B
Cash
$291.7M
Quarterly Burn
$47.7M
Runway
18.8 mo
Revenue
$24.6M
Cash Runway vs Catalysts
Tracked catalysts land within the current projected cash runway.
Pipeline (2 candidates)
| Drug | Phase |
|---|---|
| assure wcd | Approved |
| assure wearable cardioverter defibrillator system | Approved |
Institutional Holdings
Source: SEC Form 13F · as of Mar 2026Institutional holders
102
Total value held
$1.03B
| Holder | Shares | Value |
|---|---|---|
| bain capital investors llc | 25,172,338 | $501.7M |
| fmr llc | 5,721,054 | $114.0M |
| andera partners | 2,695,192 | $53.7M |
| vanguard capital management llc | 2,425,386 | $48.3M |
| alliancebernstein l.p. | 1,320,374 | $35.0M |
| brown advisory inc | 1,723,730 | $34.4M |
| blackrock, inc. | 1,689,247 | $33.7M |
| eventide asset management, llc | 1,445,864 | $28.8M |
| franklin resources inc | 1,243,205 | $24.8M |
| omega fund management, llc | 1,022,149 | $20.4M |
Showing top 10 of 102 institutional holders of Kestra Medical Technologies Ltd.. Sign up for the full 13F holder list and quarter-by-quarter ownership history.
Frequently asked questions
How many drug candidates are in Kestra Medical Technologies Ltd.'s pipeline?
Kestra Medical Technologies Ltd. (KMTS) has 2 pipeline candidates tracked by BioSniper across SEC filings and clinical trial registrations.
What is Kestra Medical Technologies Ltd.'s lead drug candidate?
Kestra Medical Technologies Ltd.'s most advanced tracked candidate is assure wcd (Approved) for Cardiac Recovery System.
What is Kestra Medical Technologies Ltd.'s cash runway?
Based on its most recent reported cash balance and quarterly burn rate, Kestra Medical Technologies Ltd. has approximately 18.8 months of cash runway.
What is Kestra Medical Technologies Ltd.'s market capitalization?
Kestra Medical Technologies Ltd.'s market capitalization is approximately $1.1B.
Who is the CEO of Kestra Medical Technologies Ltd.?
Mr. Brian Webster is the chief executive officer of Kestra Medical Technologies Ltd. (KMTS).
Get the full picture on Kestra Medical Technologies Ltd.
Deep pipeline analysis, financial trends, AI-powered investment signals, and real-time catalyst alerts.